Literature DB >> 15661404

G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Evangelia Yannaki1, Evangelia Athanasiou, Angeliki Xagorari, Varnavas Constantinou, Ioannis Batsis, Panagiotis Kaloyannidis, Evangelia Proya, Achilles Anagnostopoulos, Athanasios Fassas.   

Abstract

OBJECTIVE: On the basis of the recently recognized potential of bone marrow (BM) cells to give rise to hepatocytes, we investigated the possibility that granulocyte colony-stimulating factor (G-CSF)-mobilized BM cells could home to the injured liver and promote tissue repair. We also examined the origin of cells (endogenous or BM) reconstituting liver after damage.
METHODS: Acute and chronic liver injury models were generated by injecting CCl4 in C57Bl6 mice and G-CSF was administered in hematopoietic stem cell (HSC) mobilization doses. After sex-mismatched BM transplantation into lethally irradiated recipients and treatment with CCl4 +/- G-CSF, sry (sex-determining region for Y chromosome) protein was detected by immunohistochemistry in liver sections. Double immunohistochemistry for sry and ki-67 protein was used to define the origin of proliferating cells reconstituting liver after injury.
RESULTS: In both acute and chronic liver injury model, G-CSF administration ameliorated the histological damage and accelerated the regeneration process. This was accompanied by a strong survival benefit in G-CSF-treated group vs CCl4 group. Quantitative analysis showed higher percentage of BM-origin hepatocytes in the CCl4+G-CSF group compared with the CCl4 group, although the liver engraftment rate still remained rather low. Double staining for ki-67 and sry demonstrated that the recovery acceleration after chemical injury and G-CSF treatment was mainly mediated by increased proliferation of host hepatocytes (ki-67(+)/sry(-)) with less support from BM-origin cells (ki-67(+)/sry(+)).
CONCLUSION: G-CSF treatment significantly improved survival and liver histology in chemically injured mice, predominantly by promoting endogenous repair mechanisms. Therefore, mobilization with G-CSF might offer a novel therapeutic approach for the treatment of acute and chronic liver diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661404     DOI: 10.1016/j.exphem.2004.09.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  54 in total

Review 1.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 2.  Stem cells for end stage liver disease: how far have we got?

Authors:  Stefania Lorenzini; Stefano Gitto; Elena Grandini; Pietro Andreone; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 3.  Stem cell therapy for inherited metabolic disorders of the liver.

Authors:  Susan Ellor; Thomas Shupe; Bryon Petersen
Journal:  Exp Hematol       Date:  2008-04-02       Impact factor: 3.084

4.  Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.

Authors:  A Marmotti; F Castoldi; R Rossi; S Marenco; A Risso; M Ruella; A Tron; A Borrè; D Blonna; C Tarella
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-08-08       Impact factor: 4.342

5.  Granulocyte colony-stimulating factor prevents loss of spermatogenesis after sterilizing busulfan chemotherapy.

Authors:  Roberto Benavides-Garcia; Rose Joachim; Nancy A Pina; Kazadi N Mutoji; Matthew A Reilly; Brian P Hermann
Journal:  Fertil Steril       Date:  2014-11-05       Impact factor: 7.329

Review 6.  Alcohol abuse and disorder of granulopoiesis.

Authors:  Xin Shi; Angelo L DeLucia; Jianxin Bao; Ping Zhang
Journal:  Pharmacol Ther       Date:  2019-03-01       Impact factor: 12.310

7.  CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.

Authors:  Zhihong Wan; Shaoli You; Yihui Rong; Bing Zhu; Aimin Zhang; Hong Zang; Long Xiao; Guoming Xie; Shaojie Xin
Journal:  Dig Dis Sci       Date:  2012-10-25       Impact factor: 3.199

8.  Administration of granulocyte colony stimulating factor after liver transplantation leads to an increased incidence and severity of ischemic biliary lesions in the rat model.

Authors:  Olaf Dirsch; Haidong Chi; Yuan Ji; Yan Li Gu; Christoph E Broelsch; Uta Dahmen
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

9.  G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure.

Authors:  Yan Lei; Zhengwen Liu; Qunying Han; Wen Kang; Lei Zhang; Sai Lou
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

Review 10.  Aesthetic cardiology: adipose-derived stem cells for myocardial repair.

Authors:  Nathan J Palpant; Joseph M Metzger
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.